| Trial ID: | L3894 |
| Source ID: | NCT03598738
|
| Associated Drug: |
Esomeprazole 40mg
|
| Title: |
The Effect of Esomeprazole on Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: Esomeprazole 40mg
|
| Outcome Measures: |
Primary: HbA1c change, HbA1c change with esomeprazole in 3 months, 3 months |
|
| Sponsor/Collaborators: |
Sponsor: Baskent University Ankara Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
32
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2015-12-01
|
| Completion Date: |
2017-12-01
|
| Results First Posted: |
|
| Last Update Posted: |
2018-07-26
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT03598738
|
